The treatment of allergic rhinitis and chronic urticaria has improved markedly over the past few years as a result of our better understanding of the mechanisms of allergic disease and the availability of effective treatments.
Bilastine is a new addition to the family of non-sedating H1 antihistamines. In this symposium, we have the privilege of presenting a renowned panel of experts to present the scientific and clinical evidence regarding the use of bilastine in the treatment of allergic rhinitis and chronic urticaria.
